학술논문
Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15357163